Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Noncontrast MR Lymphography in Secondary Lower Limb Lymphedema:

View through CrossRef
BackgroundInvasive imaging techniques have been applied for lymphedema (LE) assessment; noncontrast MR lymphography (NCMLR) has potential as an alternative, but its performance is not known in secondary lower limb LE.PurposeTo assess the role of NCMRL for the classification and characterization of secondary lower limb LE.Study TypeRetrospective.PopulationFifty adults with clinically diagnosed secondary LE.Field Strength/Sequence1.5T, 3D T2‐weighted turbo spin‐echo, 3D T2‐weighted turbo spin‐echo short tau inversion recovery.AssessmentThree radiologists assessed the following characteristics on NCMRL: honeycomb pattern, dermal thickening, muscular abnormalities, distal dilated lymphatics, inguinal lymph node number, appearance of iliac lymphatic trunks. An LE grading based on the MR images was assigned. The relationship between imaging findings and clinical staging was evaluated, as well as between dermal backflow at lymphoscintigraphy and MR staging, and between the limb swelling duration and peripheral lymphatics dilatation.Statistical TestsPearson's correlation test and Cramer's V coefficient were computed to measure the strength of association. The Mann–Whitney test was used to compare the limb swelling duration between patients with and without dilated distal vessels. Agreement among raters was assessed through Kendall's W coefficient of correlation.ResultsClinical stage and the MR grading were correlated, with Cramer's V coefficient of 1 for reader 1 (P < 0.05), 0.846 for reader 2 (P < 0.05), and 0.912 (P < 0.05) for reader 3; agreement between interraters was very good (W = 0.0.75; P = 0.05). A honeycomb pattern (P < 0.05), dermal thickening (P < 0.001), muscular abnormalities (P < 0.05), iliac lymphatic trunks appearance (P < 0.05), distal dilated vessels (P < 0.05), and lymph nodes number (P < 0.05) were significantly correlated with LE clinical stage. Dermal backflow at lymphoscintigraphy was described in 10 (20%) patients and showed a significant correlation with the MR grading (P < 0.05).Data ConclusionThese preliminary results suggest that NCMRL may provide information useful for the staging and management of patients affected by secondary lower limb LE.Level of Evidence 4Technical Efficacy Stage 2J. MAGN. RESON. IMAGING 2021;53:458–466.
Title: Noncontrast MR Lymphography in Secondary Lower Limb Lymphedema:
Description:
BackgroundInvasive imaging techniques have been applied for lymphedema (LE) assessment; noncontrast MR lymphography (NCMLR) has potential as an alternative, but its performance is not known in secondary lower limb LE.
PurposeTo assess the role of NCMRL for the classification and characterization of secondary lower limb LE.
Study TypeRetrospective.
PopulationFifty adults with clinically diagnosed secondary LE.
Field Strength/Sequence1.
5T, 3D T2‐weighted turbo spin‐echo, 3D T2‐weighted turbo spin‐echo short tau inversion recovery.
AssessmentThree radiologists assessed the following characteristics on NCMRL: honeycomb pattern, dermal thickening, muscular abnormalities, distal dilated lymphatics, inguinal lymph node number, appearance of iliac lymphatic trunks.
An LE grading based on the MR images was assigned.
The relationship between imaging findings and clinical staging was evaluated, as well as between dermal backflow at lymphoscintigraphy and MR staging, and between the limb swelling duration and peripheral lymphatics dilatation.
Statistical TestsPearson's correlation test and Cramer's V coefficient were computed to measure the strength of association.
The Mann–Whitney test was used to compare the limb swelling duration between patients with and without dilated distal vessels.
Agreement among raters was assessed through Kendall's W coefficient of correlation.
ResultsClinical stage and the MR grading were correlated, with Cramer's V coefficient of 1 for reader 1 (P < 0.
05), 0.
846 for reader 2 (P < 0.
05), and 0.
912 (P < 0.
05) for reader 3; agreement between interraters was very good (W = 0.
75; P = 0.
05).
A honeycomb pattern (P < 0.
05), dermal thickening (P < 0.
001), muscular abnormalities (P < 0.
05), iliac lymphatic trunks appearance (P < 0.
05), distal dilated vessels (P < 0.
05), and lymph nodes number (P < 0.
05) were significantly correlated with LE clinical stage.
Dermal backflow at lymphoscintigraphy was described in 10 (20%) patients and showed a significant correlation with the MR grading (P < 0.
05).
Data ConclusionThese preliminary results suggest that NCMRL may provide information useful for the staging and management of patients affected by secondary lower limb LE.
Level of Evidence 4Technical Efficacy Stage 2J.
MAGN.
RESON.
IMAGING 2021;53:458–466.

Related Results

Epidemiological data on lower limb lymphedema
Epidemiological data on lower limb lymphedema
Objective: The aim of the present study was to evaluate epidemiological data of patients seen at a clinic specialized in the treatment of lymphedema. Methods: A retrospective, cro...
Efficacy of Ultrasound and Shear Wave Elastography for the Diagnosis of Breast Cancer–Related Lymphedema
Efficacy of Ultrasound and Shear Wave Elastography for the Diagnosis of Breast Cancer–Related Lymphedema
Objectives To assess the feasibility of ultrasound and shear wave elastography (SWE) in the diagnosis of breast cancer–related lymphedema. ...
An Enhanced Self-Care Protocol for People Affected by Moderate to Severe Lymphedema
An Enhanced Self-Care Protocol for People Affected by Moderate to Severe Lymphedema
Lymphedema is a chronic skin disease that has many causes and leads to significant disfigurement and disability worldwide. Recommendations for lymphedema self-care vary by setting ...
Lympedema Therapies
Lympedema Therapies
Secondary lymphedema refers to a condition in which the affected extremity develops progressive hypertrophy due to lymphatic fluid retention. Worldwide, secondary lymphedema is mos...
Anti-CTLA4 treatment reduces lymphedema risk through a systemic expansion of the FOXP3+ Treg population
Anti-CTLA4 treatment reduces lymphedema risk through a systemic expansion of the FOXP3+ Treg population
Abstract Secondary lymphedema is a common sequel of oncologic surgery following lymphatic injury and presents a substantial global health burden for which no pharmacologica...
Timeframe for lymphedema therapy for head and neck cancer survivors.
Timeframe for lymphedema therapy for head and neck cancer survivors.
e13535 Background: More than 90% of head and neck cancer (HNC) survivors experience secondary head and neck lymphedema. Prompt identification and treatment are essential given the...
Diagnosis of Lymphatic Dysfunction by Evaluation of Lymphatic Degeneration with Lymphatic Ultrasound
Diagnosis of Lymphatic Dysfunction by Evaluation of Lymphatic Degeneration with Lymphatic Ultrasound
Background: The standard examination for diagnosing lymphedema is lymphoscintigraphy, which has a disadvantage in versatility and radiation exposure. We have re...

Back to Top